Literature DB >> 303135

Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men.

C Larsson, S Eriksson, H Dirksen.   

Abstract

Lung function was evaluated in a representative population sample of 50-year-0ld men living in one Swedish city. Twenty-four smoking and 15 non-smoking men heterozygous for alpha1-antitrypsin deficiency--that is, with the protease-inhibitor (Pi1 phenotype MZ--were carefully matched for weight and smoking habit with Pi M controls. The pulmonary function of non-smoking Pi MZ subjects did not differ from that of non-smoking Pi M controls. In contrast, smoking heterozygotes showed a significant loss of elastic recoil, enlarged residual volumes, and increased closing capacity but no signs of obstructive ventilatory impairment. Most smoking Pi MZ individuals reported mild exertional dyspnoea.

Entities:  

Mesh:

Year:  1977        PMID: 303135      PMCID: PMC1631597          DOI: 10.1136/bmj.2.6092.922

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  Efficiency of pulmonary ventilation during rest and light exercise; a study of alveolar nitrogen wash-out curves in normal subjects.

Authors:  A BOUHUYS; K E HAGSTAM; G LUNDIN
Journal:  Acta Physiol Scand       Date:  1956-02-20

2.  The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1973-07-16

3.  Nitrogen and 133xenon closing volumes in healthy non-smokers.

Authors:  H Dirksen; M Arborelius; B Lilja
Journal:  Scand J Respir Dis Suppl       Date:  1974

4.  Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.

Authors:  J O Morse; M D Lebowitz; R J Knudson; B Burrows
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

5.  The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1974-03-01

Review 6.  Alpha1-antitrypsin and its deficiency.

Authors:  F Kueppers; L F Black
Journal:  Am Rev Respir Dis       Date:  1974-08

7.  Respiratory disease profile in 22 patients with alpha 1-antitrypsin deficiencies.

Authors:  E Varpela; Y Salorinne
Journal:  Scand J Respir Dis Suppl       Date:  1974

8.  Determinants of chronic obstructive pulmonary disease in patients with intermediate levels of alpha-antitrypsin.

Authors:  R Klayton; R Fallat; A B Cohen
Journal:  Am Rev Respir Dis       Date:  1975-07

9.  Pulmonary function in nonsmoking subjects with alpha1 antitrypsin deficiency (MZ phenotype).

Authors:  A F Gelb; E Klein; J Lieberman
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

10.  Decrease in ventilatory capacity between ages of 50 and 54 in representative sample of Swedish men.

Authors:  L Wilhelmsen; I Orha; G Tibblin
Journal:  Br Med J       Date:  1969-09-06
View more
  10 in total

1.  Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.

Authors:  D J McDonagh; S P Nathan; R J Knudson; M D Lebowitz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

2.  Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency.

Authors:  E J Campbell; M A Campbell; S S Boukedes; C A Owen
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 3.  Association of alpha 1-antitrypsin deficiency with lung and liver diseases.

Authors:  M Resendes
Journal:  West J Med       Date:  1987-07

Review 4.  Inherited metabolic diseases affecting the carrier.

Authors:  W Endres
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

5.  Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).

Authors:  S F Tattersall; R P Pereira; D Hunter; G Blundell; N B Pride
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

6.  Alpha 1-antitrypsin screening of 18-year-old men.

Authors:  T Sveger; P Mazodier
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

Review 7.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

8.  Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers.

Authors:  A Wallmark; R Alm; S Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband.

Authors:  S Anand; R R Schade; C Bendetti; R Kelly; B S Rabin; J Krause; T E Starzl; S Iwatsuki; D H Van Thiel
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

Review 10.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.